216 related articles for article (PubMed ID: 26484928)
1. Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
Wu HZ; Ong KL; Seeher K; Armstrong NJ; Thalamuthu A; Brodaty H; Sachdev P; Mather K
J Alzheimers Dis; 2016; 49(3):755-66. PubMed ID: 26484928
[TBL] [Abstract][Full Text] [Related]
2. Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis.
Shi D; Han M; Liu W; Tao J; Chen L
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520951686. PubMed ID: 33094634
[TBL] [Abstract][Full Text] [Related]
3. The role of microRNAs in understanding sex-based differences in Alzheimer's disease.
Llera-Oyola J; Carceller H; Andreu Z; Hidalgo MR; Soler-Sáez I; Gordillo F; Gómez-Cabañes B; Roson B; de la Iglesia-Vayá M; Mancuso R; Guerini FR; Mizokami A; García-García F
Biol Sex Differ; 2024 Jan; 15(1):13. PubMed ID: 38297404
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicle-Enriched miRNA-Biomarkers Show Improved Utility for Detecting Alzheimer's Disease Dementia and Medial Temporal Atrophy.
Chai YL; Strohm L; Zhu Y; Chia RSL; Chong JR; Suresh DD; Zhou LH; Too HP; Hilal S; Radivoyevitch T; Koo EH; Chen CP; Poplawski GHD
J Alzheimers Dis; 2024; 99(4):1317-1331. PubMed ID: 38788066
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis.
Ogonowski N; Salcidua S; Leon T; Chamorro-Veloso N; Valls C; Avalos C; Bisquertt A; Rentería ME; Orellana P; Duran-Aniotz C
Front Aging Neurosci; 2021; 13():807764. PubMed ID: 35095478
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease.
Kumar A; Su Y; Sharma M; Singh S; Kim S; Peavey JJ; Suerken CK; Lockhart SN; Whitlow CT; Craft S; Hughes TM; Deep G
Alzheimers Dement; 2023 Nov; 19(11):4952-4966. PubMed ID: 37071449
[TBL] [Abstract][Full Text] [Related]
7. The plasma derived exosomal miRNA-483-5p/502-5p serve as potential MCI biomarkers in aging.
Liu T; Li N; Pu J; Zhang C; Xu K; Wang W; Liu L; Gao L; Xu X; Tan J
Exp Gerontol; 2024 Feb; 186():112355. PubMed ID: 38190948
[TBL] [Abstract][Full Text] [Related]
8. Identification and diagnostic potential of serum microRNAs as biomarkers for early detection of Alzheimer's disease.
Han YH; Xiang HY; Lee DH; Feng L; Sun HN; Jin MH; Kwon T
Aging (Albany NY); 2023 Nov; 15(21):12085-12103. PubMed ID: 37916989
[TBL] [Abstract][Full Text] [Related]
9. miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach.
Pereira JD; Teixeira LCR; Mamede I; Alves MT; Caramelli P; Luizon MR; Veloso AA; Gomes KB
J Neurochem; 2024 Jun; 168(6):977-994. PubMed ID: 38390627
[TBL] [Abstract][Full Text] [Related]
10. Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study.
Sheinerman KS; Tsivinsky VG; Abdullah L; Crawford F; Umansky SR
Aging (Albany NY); 2013 Dec; 5(12):925-38. PubMed ID: 24368295
[TBL] [Abstract][Full Text] [Related]
11. Urinary Cytokines as Potential Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.
Saiyed N; Yilmaz A; Vishweswariah S; Maiti AK; Ustun I; Bartolone S; Brown-Hughes T; Thorpe RJ; Osentoski T; Ruff S; Pai A; Maddens M; Imam K; Graham SF
J Alzheimers Dis Rep; 2023; 7(1):649-657. PubMed ID: 37483327
[TBL] [Abstract][Full Text] [Related]
12. miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.
Mushtaq G; Greig NH; Anwar F; Zamzami MA; Choudhry H; Shaik MM; Tamargo IA; Kamal MA
Med Chem; 2016; 12(3):217-25. PubMed ID: 26527155
[TBL] [Abstract][Full Text] [Related]
13. Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning.
Yuen SC; Liang X; Zhu H; Jia Y; Leung SW
Alzheimers Res Ther; 2021 Jul; 13(1):126. PubMed ID: 34243793
[TBL] [Abstract][Full Text] [Related]
14. miRNA as an Ultimate and Emerging Diagnostic Approach for the Detection of Alzheimer's Disease.
Jain M; Agarwal S; Rana A; Tiwari A; Patil N
Microrna; 2023; 12(3):189-204. PubMed ID: 37859330
[TBL] [Abstract][Full Text] [Related]
15. Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? A systematic review.
Chiam JT; Dobson RJ; Kiddle SJ; Sattlecker M
J Alzheimers Dis; 2015; 43(1):303-14. PubMed ID: 25096613
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease.
Noor Eddin A; Hamsho K; Adi G; Al-Rimawi M; Alfuwais M; Abdul Rab S; Alkattan K; Yaqinuddin A
Front Aging Neurosci; 2023; 15():1210191. PubMed ID: 37476007
[TBL] [Abstract][Full Text] [Related]
17. A critical appraisal of the circulating levels of differentially expressed microRNA in endometriosis†.
Leonova A; Turpin VE; Agarwal SK; Leonardi M; Foster WG
Biol Reprod; 2021 Nov; 105(5):1075-1085. PubMed ID: 34244742
[TBL] [Abstract][Full Text] [Related]
18. Biomarker profiling to determine clinical impact of microRNAs in cognitive disorders.
Zhai W; Zhao M; Wei C; Zhang G; Qi Y; Zhao A; Sun L
Sci Rep; 2024 Apr; 14(1):8270. PubMed ID: 38594359
[TBL] [Abstract][Full Text] [Related]
19. Identification of molecular alterations in leukocytes from gene expression profiles of peripheral whole blood of Alzheimer's disease.
Li H; Hong G; Lin M; Shi Y; Wang L; Jiang F; Zhang F; Wang Y; Guo Z
Sci Rep; 2017 Oct; 7(1):14027. PubMed ID: 29070791
[TBL] [Abstract][Full Text] [Related]
20. Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.
Nair VS; Pritchard CC; Tewari M; Ioannidis JP
Am J Epidemiol; 2014 Jul; 180(2):140-52. PubMed ID: 24966218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
